Azhar Ali

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 9

Top Venues

Pharmaceuticals (Basel, Switzerland)

Cancer research communications

Cancers

EMBO molecular medicine

National University of Singapore

National University of Singapore (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

National University of Singapore

Singapore

Senior Research Scientist :: Cancer Science Institute of Singapore

Education History

National University of Singapore

Singapore

PHD :: Department of Surgery

Publications

Azhar Ali
Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment-A Paradigm Shift in Oncology. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, Valerie A Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang, Marla Weetall, Arthur Branstrom, Giulia Braccini, Eva Cabrera San Millán, Barbara Storti, Ranieri Bizzarri, Olivier Kocher, Daniela Sanchez Bassères, Robert S Welner, Maria Cristina Magli, Ivan Merelli, John Gerard Clohessy, Azhar Ali, Daniel Geoffrey Tenen, Elena Levantini
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment. Cancer research communications 4 (3) (2024)
Giorgia Maroni, Indira Krishnan, Roberta Alfieri, Valerie A Maymi, Nicole Pandell, Eva Csizmadia, Junyan Zhang, Marla Weetall, Arthur Branstrom, Giulia Braccini, Eva Cabrera San Millán, Barbara Storti, Ranieri Bizzarri, Olivier Kocher, Daniela Sanchez Bassères, Robert S Welner, Maria Cristina Magli, Ivan Merelli, John Gerard Clohessy, Azhar Ali, Daniel Geoffrey Tenen, Elena Levantini
Tumor Microenvironment Landscapes Supporting EGFR-mutant NSCLC Are Modulated at the Single-cell Interaction Level by Unesbulin Treatment. Cancer research communications 4 (3) (2024)
Azhar Ali
Advances in Non-Small Cell Lung Cancer (NSCLC) Treatment-A Paradigm Shift in Oncology. Pharmaceuticals (Basel, Switzerland) 17 (2) (2024)
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, Azhar Ali, Jonathan Chee Woei Lim
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, Azhar Ali, Jonathan Chee Woei Lim
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Thiviyadarshini Rajasegaran, Chee Wun How, Anoosha Saud, Azhar Ali, Jonathan Chee Woei Lim
Targeting Inflammation in Non-Small Cell Lung Cancer through Drug Repurposing. Pharmaceuticals (Basel, Switzerland) 16 (3) (2023)
Chee Wai Fhu, Azhar Ali
Dysregulation of the Ubiquitin Proteasome System in Human Malignancies: A Window for Therapeutic Intervention. Cancers 13 (7) (2021)
Azhar Ali, Elena Levantini, Jun Ting Teo, Julian Goggi, John G Clohessy, Chan Shuo Wu, Leilei Chen, Henry Yang, Indira Krishnan, Olivier Kocher, Junyan Zhang, Ross A Soo, Kishore Bhakoo, Tan Min Chin, Daniel Geoffrey Tenen
Fatty acid synthase mediates EGFR palmitoylation in EGFR mutated non-small cell lung cancer. EMBO molecular medicine 10 (3) (2019)

Azhar Ali.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Azhar Ali